Therefore, cardiac CAPNS1 can be explored for the molecular signaling involving the onset, progression and prognostic in T2D patients with SARS-CoV-2 infection and holding promise for using as a biomarker and potential therapeutic target in anti-SARS-CoV-2 comprehensive therapy. This evidence concerns the gene CAPNS1 and type 2 diabetes mellitus.